LEXICON PHARMACEUTICALS, INC. Quarterly Other Assets, Noncurrent in USD from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Lexicon Pharmaceuticals, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2010 to Q2 2024.
  • Lexicon Pharmaceuticals, Inc. Other Assets, Noncurrent for the quarter ending June 30, 2024 was $828K, a 86.8% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $828K -$5.43M -86.8% Jun 30, 2024 10-Q 2024-08-02
Q1 2024 $828K -$5.59M -87.1% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $828K +$416K +101% Dec 31, 2023 10-Q 2024-08-02
Q3 2023 $743K -$6.4M -89.6% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $6.26M +$4.41M +239% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $6.42M +$4.36M +211% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $412K -$1.86M -81.8% Dec 31, 2022 10-K 2024-03-25
Q3 2022 $7.15M +$4.68M +189% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $1.85M -$821K -30.7% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $2.06M -$943K -31.4% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $2.27M +$1.04M +84.3% Dec 31, 2021 10-Q 2022-11-09
Q3 2021 $2.47M +$1.13M +84.3% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $2.67M +$1.22M +84.4% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $3.01M +$1.45M +93.5% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $1.23M -$424K -25.6% Dec 31, 2020 10-K 2022-03-10
Q3 2020 $1.34M -$413K -23.5% Sep 30, 2020 10-Q 2020-10-30
Q2 2020 $1.45M -$450K -23.7% Jun 30, 2020 10-Q 2020-07-29
Q1 2020 $1.55M -$440K -22.1% Mar 31, 2020 10-Q 2020-04-27
Q4 2019 $1.66M +$1.37M +481% Dec 31, 2019 10-K 2021-03-12
Q3 2019 $1.75M +$1.33M +309% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $1.9M +$1.47M +342% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $1.99M +$1.56M +361% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $285K -$144K -33.6% Dec 31, 2018 10-K 2020-03-12
Q3 2018 $429K $0 0% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 $429K +$1K +0.23% Jun 30, 2018 10-Q 2018-07-30
Q1 2018 $432K +$4K +0.94% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 $429K -$32K -6.94% Dec 31, 2017 10-K 2019-03-15
Q3 2017 $429K -$25K -5.51% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $428K -$2K -0.47% Jun 30, 2017 10-Q 2017-08-01
Q1 2017 $428K -$102K -19.2% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 $461K +$28K +6.47% Dec 31, 2016 10-K 2018-03-01
Q3 2016 $454K -$3.04M -87% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 $430K -$3.15M -88% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 $530K -$3.21M -85.8% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 $433K -$2.98M -87.3% Dec 31, 2015 10-K 2017-03-06
Q3 2015 $3.5M +$3.39M +3139% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $3.58M +$3.46M +2884% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 $3.74M +$3.61M +2712% Mar 31, 2015 10-Q 2015-05-05
Q4 2014 $3.41M +$3.27M +2267% Dec 31, 2014 10-K 2016-03-11
Q3 2014 $108K -$50K -31.6% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 $120K +$55K +84.6% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $133K +$45K +51.1% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 $144K +$35K +32.1% Dec 31, 2013 10-K 2015-03-12
Q3 2013 $158K +$23K +17% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $65K -$92K -58.6% Jun 30, 2013 10-Q 2013-08-01
Q1 2013 $88K -$93K -51.4% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 $109K -$96K -46.8% Dec 31, 2012 10-K 2014-03-07
Q3 2012 $135K -$146K -52% Sep 30, 2012 10-Q 2012-11-07
Q2 2012 $157K -$96K -37.9% Jun 30, 2012 10-Q 2012-08-02
Q1 2012 $181K Mar 31, 2012 10-Q 2012-05-03
Q4 2011 $205K -$414K -66.9% Dec 31, 2011 10-K 2013-03-11
Q3 2011 $281K Sep 30, 2011 10-Q 2011-11-01
Q2 2011 $253K Jun 30, 2011 10-Q 2011-08-09
Q4 2010 $619K Dec 31, 2010 10-K 2012-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.